Path
Path
Want to make a donation using Daffy?
Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.
Do you work for Path? Learn more here.
About this organization
Mission
When people everywhere have a path to good health, people, communities, and economies thrive. At PATH, our mission is to advance health equity through innovation and partnerships. Our global team of innovators advises and partners with institutions, investors, and businesses of all sizes to solve the world’s most pressing health challenges. Because better health moves humanity forward. Our team includes scientists, health experts, business leaders, engineers, advocates, and experts from dozens of other specialties. We work in more than 70 countries to transform bold ideas into sustainable solutions that improve health and well-being for all.
About
GLOBAL HEALTH PROGRAMS: PATH'S GLOBAL HEALTH PROGRAMS DIVISION BRINGS TOGETHER OUR SIGNIFICANT COUNTRY EXPERIENCE AND DEEP TECHNICAL EXPERTISE TO FACILITATE THE ORGANIZATION'S ABILITY TO ACHIEVE IMPACT THROUGH INNOVATIVE APPROACHES AND SOLUTIONS. THIS DIVISION MANAGES PATH'S PRESENCE IN COUNTRY OFFICES AND IS RESPONSIBLE FOR PATH'S SCIENTIFIC EXPERTISE IN MALARIA AND NEGLECTED TROPICAL DISEASES; HIV AND TUBERCULOSIS; MATERNAL, NEWBORN, AND CHILD HEALTH AND NUTRITION; SEXUAL AND REPRODUCTIVE HEALTH; NONCOMMUNICABLE DISEASES; HEALTH SYSTEMS INNOVATION AND DELIVERY; AND DIGITAL HEALTH SOLUTIONS.(CONTINUED ON SCHEDULE O)MALARIA AND NEGLECTED TROPICAL DISEASESPATH PARTNERS WITH GOVERNMENTS, THE PRIVATE SECTOR, AND FUNDERS ACROSS THE GLOBE TO BRING THE WORLD CLOSER TO MALARIA ERADICATION. MORE THAN 200 PATH STAFF MEMBERS WORK ON MALARIA IN MORE THAN 30 COUNTRIES. OUR STRATEGY INCLUDES OPTIMIZING THE DELIVERY OF CURRENT TOOLS AND APPROACHES TO ENSURE THEY REACH THE PEOPLE WHO NEED THEM, DEVELOPING NEW STRATEGIES FOR ELIMINATION, DEVELOPING NEXT-GENERATION TOOLS TO OVERCOME EMERGING CHALLENGES, AND CREATING INNOVATIVE PARTNERSHIPS AND FUNDING MODELS TO ENSURE THAT OUR PROGRAMS ARE SUSTAINABLE AND EFFECTIVE. APPROACHES PIONEERED BY PATH HAVE CONTRIBUTED TO REMARKABLE PROGRESS TOWARD CONTROLLING AND ELIMINATING MALARIA, WITH NEARLY 7 MILLION LIVES SAVED SINCE 2000.IN 2018, OUR MALARIA CONTROL AND ELIMINATION PARTNERSHIP IN AFRICA (MACEPA) PROGRAM CONTINUED TO SUPPORT THE GOVERNMENTS OF ETHIOPIA, SENEGAL, AND ZAMBIA AS THEY STRIVE TO ACHIEVE THEIR MALARIA ELIMINATION GOALS. WE HELPED BY SCALING UP PREVENTION AND TREATMENT, EVALUATING SENSITIVE DIAGNOSTIC TOOLS, ESTABLISHING RAPID REPORTING SYSTEMS, AND SUPPORTING POPULATION-WIDE, DRUG-BASED STRATEGIES, SUCH AS MASS DRUG ADMINISTRATION. THROUGH OUR PROGRAM FOR THE ADVANCEMENT OF MALARIA OUTCOMES, PATH ASSISTED THE GOVERNMENT OF ZAMBIA IN REACHING ITS GOALS FOR ELIMINATING LOCAL MALARIA INFECTION AND DISEASE. THIS WORK FOCUSED ON BEDNETS, MALARIA IN PREGNANCY, SOCIAL BEHAVIOR CHANGE, CASE MANAGEMENT, SURVEILLANCE, AND MONITORING & EVALUATION. THE PROGRAM'S GEOGRAPHIC FOCUS IS ON PROVINCES WITH THE HIGHEST MALARIA PREVALENCE AMONG CHILDREN.PATH ALSO WORKED TO IMPROVE DATA FOR MALARIA CONTROL DECISION-MAKING AND SURVEILLANCE. IN ZAMBIA, FOR EXAMPLE, THE VISUALIZE NO MALARIA PROJECT-A GROUNDBREAKING PARTNERSHIP WITH A SEATTLE-BASED SOFTWARE COMPANY AND A COALITION OF OTHER TECHNOLOGY COMPANIES-CONTINUED TO EXPAND. THIS PROJECT EQUIPS HEALTH WORKERS AND OFFICIALS WITH REAL-TIME DATA VISUALIZATION TOOLS TO SEE WHERE MALARIA IS APPEARING SO THEY CAN DEPLOY RESOURCES TO HALT ITS SPREAD. IN WESTERN KENYA, PATH ASSESSED THE POTENTIAL CONTRIBUTION OF MALARIA TESTING DATA FROM PREGNANT WOMEN ATTENDING ANTENATAL CLINICS AS A MEANS TO BOLSTER SURVEILLANCE.IN 2018, PATH ALSO WORKED WITH THE WORLD HEALTH ORGANIZATION (WHO) AND OTHER PARTNERS TO PREPARE FOR PILOT IMPLEMENTATION OF THE RTS,S MALARIA VACCINE IN SELECTED AREAS OF GHANA, KENYA, AND MALAWI. VACCINATIONS ARE DUE TO BEGIN IN 2019. PATH CONTINUED TO DEVELOP AND EVALUATE NEW VECTOR-CONTROL TOOLS SUCH AS NEXT-GENERATION INDOOR RESIDUAL SPRAYING (IN PARTNERSHIP WITH THE INNOVATIVE VECTOR CONTROL CONSORTIUM, THE US PRESIDENT'S MALARIA INITIATIVE, ABT ASSOCIATES, AND THE GLOBAL FUND). THIS WORK IS GENERATING EVIDENCE TO SUPPORT TIMELY DECISION-MAKING AROUND THE ADOPTION OF NEW INSECTICIDES THAT ARE EFFECTIVE AGAINST PYRETHROID-RESISTANT MOSQUITOES. PATH ALSO LED EVALUATION AND DATA-FOR-DECISION-MAKING ACTIVITIES UNDER VECTORLINK, THE US AGENCY FOR INTERNATIONAL DEVELOPMENT'S (USAID'S) FLAGSHIP VECTOR-CONTROL PARTNERSHIP. IN ADDITION, WE DIRECTED EVIDENCE-GENERATION ACTIVITIES UNDER THE NEW NETS PROJECT, FUNDED BY UNITAID AND THE GLOBAL FUND, TO HELP SCALE UP ACCESS TO AND USE OF NEW LONG-LASTING INSECTICIDE-TREATED NETS.TO ADDRESS THE TWIN THREATS OF INSECTICIDE RESISTANCE AND OUTDOOR BITING BY MOSQUITOES, PATH CONTINUED THE DEVELOPMENT AND EVALUATION OF ATTRACTIVE TARGETED SUGAR BAITS, WHICH PRESENT A SUGAR MEAL FOR MOSQUITOES THAT IS LACED WITH AN INSECTICIDE. PATH ALSO SUPPORTED THE DEVELOPMENT OF A NEW, HIGHLY SENSITIVE RAPID DIAGNOSTIC TEST THAT OFFERS A GREATER THAN TENFOLD IMPROVEMENT IN DETECTION OF THE MOST COMMON MALARIA PARASITE. FINALLY, WE ADVANCED WORK ON A POINT-OF-CARE DIAGNOSTIC TEST FOR GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY, A CONDITION THAT CAN COMPLICATE MALARIA TREATMENT.IN PATH'S EFFORTS TO FIGHT NEGLECTED TROPICAL DISEASES, OUR WORK INCLUDES DEFINING PRODUCT NEEDS; DEVELOPING TARGET PRODUCT PROFILES; ENGAGING WITH STAKEHOLDERS; CONDUCTING LABORATORY AND FIELD TESTS AND EVALUATIONS; TRANSFERRING TECHNOLOGY AND SECURING MANUFACTURING, DEVELOPMENT, AND COMMERCIALIZATION AGREEMENTS; COMMERCIALIZING PRODUCTS AND COLLATERAL; AND SUPPORTING PRODUCT LAUNCH. MUCH OF THIS WORK IS ACCOMPLISHED VIA PATH'S TECHNOLOGY, ANALYTICS, AND MARKET INNOVATION DIVISION.HIV AND TUBERCULOSISPATH CONTINUED TO CONTRIBUTE TO HIV PREVENTION AND EPIDEMIC CONTROL IN 2018 BY FOCUSING PROGRAMMING ON THE KEY AND HIGH-PRIORITY POPULATIONS OF ADOLESCENT GIRLS AND YOUNG WOMEN, PEOPLE WITH BOTH HIV AND TUBERCULOSIS (TB), SEX WORKERS AND THEIR CLIENTS, MEN WHO HAVE SEX WITH MEN, PEOPLE WHO INJECT DRUGS, AND TRANSGENDER INDIVIDUALS. WE ADVANCED PROGRAMMING ACROSS MULTIPLE TECHNOLOGY AND SERVICE DELIVERY PLATFORMS-FROM DEVICES, TOOLS, AND DIAGNOSTICS TO SERVICE DELIVERY INNOVATIONS AND ADVOCACY. PATH'S WORK IN DIAGNOSTICS FOCUSED ON FILLING GAPS IN FOUR CRITICAL AREAS: SELF-TESTING, EARLY INFANT DIAGNOSIS, TB DETECTION AMONG PEOPLE LIVING WITH HIV, AND VIRAL LOAD DETECTION. WE FOCUSED ON UNDERSTANDING THE BARRIERS THAT RESTRICT ACCESS TO HIGH-QUALITY DIAGNOSTICS AND ADVANCING NEW PRODUCTS TO OVERCOME THESE OBSTACLES. TO INFORM DESIGN AND DELIVERY OF NEXT-GENERATION HIV SELF-TESTS, PATH EMPLOYED USER-CENTERED DESIGN METHODOLOGIES TO CREATE USER PERSONAS REPRESENTING KEY POPULATIONS. PATH ALSO WORKED TO EVALUATE AND ADVANCE DEVICES TO PROVIDE LONG-TERM ANTIRETROVIRAL DELIVERY FOR PRE-EXPOSURE PROPHYLAXIS (PREP) AND HIV TREATMENT. THESE DEVICES INCLUDE MICROARRAY PATCHES FOR TRANSDERMAL DELIVERY AND AN APPLICATOR TO SUBCUTANEOUSLY INSERT BIODEGRADABLE IMPLANTS. WE ALSO WORKED ON A PEDIATRIC-FRIENDLY DOSAGE FORM OF ANTIRETROVIRAL DRUGS, USING OUR FAST-DISSOLVING TABLET TECHNOLOGY.THROUGH THE AIDS, POPULATION, AND HEALTH INTEGRATED ASSISTANCE PROGRAM PLUS (APHIAPLUS PROJECT), PATH HELPED TO INTEGRATE HEALTH SERVICES IN WESTERN KENYA AND ENABLE MORE PEOPLE TO ACCESS A GREATER SPECTRUM OF SERVICES. SINCE 2011, THE PATH-LED TEAM HAS BUILT THE CAPACITY OF HEALTH CARE WORKERS AND FACILITIES TO DELIVER HIGH-QUALITY SERVICES FOR HIV, TB, SEXUAL AND REPRODUCTIVE HEALTH, AND ADOLESCENT HEALTH; STRENGTHENED LINKAGES BETWEEN HEALTH FACILITIES AND COMMUNITIES TO EXPEDITE ACCESS TO HIV CARE AND TREATMENT; ESTABLISHED COMMUNITY SUPPORT SYSTEMS FOR PEOPLE LIVING WITH HIV AND THEIR FAMILIES; AND EMPOWERED AND MOBILIZED COMMUNITIES AROUND HIV PREVENTION AND OUTREACH.IN 2018, PATH TRANSITIONED HIV ACTIVITIES IN KENYA'S FORMER NYANZA PROVINCE TO USAID'S PATH-LED AFYA ZIWANI PROJECT, WHILE CONTINUING HIV AND TB SERVICE DELIVERY IN THE FORMER WESTERN PROVINCE THROUGH APHIAPLUS. WITH FUNDING FROM THE US PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF DREAMS INITIATIVE, APHIAPLUS AND THE AFYA ZIWANI PROJECT INTENSIFIED EFFORTS TO REACH MORE THAN 77,500 ADOLESCENT GIRLS AND YOUNG WOMEN IN KENYA WITH INTERVENTIONS TO REDUCE THEIR VULNERABILITY TO HIV AND IMPROVE THEIR ACCESS TO SERVICES. THIS WORK INCLUDED THE CREATION OF MORE THAN 200 SAFE SPACES AND IMPROVED ACCESS TO YOUTH-FRIENDLY FAMILY PLANNING, HIV, AND GENDER-BASED VIOLENCE SERVICES. IN THE DEMOCRATIC REPUBLIC OF THE CONGO (DRC), PATH CONTINUED TO LEAD USAID-FUNDED EFFORTS TO IMPROVE HIV/AIDS SERVICES. IN 2018, THIS WORK FOCUSED ON TWO HIGH-PREVALENCE PROVINCES UNDER THE INTEGRATED HIV/AIDS PROJECT IN HAUT-KATANGA AND LUALABA. PATH PROVIDED TECHNICAL ASSISTANCE TO 162 HEALTH FACILITIES, 18 HEALTH ZONES, AND 5 NONGOVERNMENTAL ORGANIZATIONS TO INCREASE TARGETED TESTING EFFORTS, ENROLL ALL IDENTIFIED HIV-POSITIVE INDIVIDUALS ON TREATMENT, SCALE UP VIRAL LOAD TESTING, AND ROLL OUT DIFFERENTIATED CARE MODELS TO IMPROVE RETENTION IN TREATMENT. AT THE END OF DECEMBER 2018, PATH WAS SUPPORTING MORE THAN 33,000 INDIVIDUALS IN THE DRC ON ANTIRETROVIRAL THERAPY.
Interesting data from their 2020 990 filing
In the filing, the mission of the non-profit is noted as “Path's mission is to advance health equity through innovation and partnerships. (continued on schedule o)”.
When referring to its responsibilities, they were outlined as: “See part iii, line 1.”.
- The state in which the non-profit is legally registered to operate is WA, as per legal records.
- The filing documents the non-profit's address in 2020 as 2201 WESTLAKE AVENUE NO 200, SEATTLE, WA, 98121.
- According to the non-profit's form, they have 787 employees on their payroll as of 2020.
- Is not a private foundation.
- Expenses are greater than $1,000,000.
- Revenue is greater than $1,000,000.
- Revenue less expenses is -$3,432,058.
- The organization has 14 independent voting members.
- The organization was formed in 1981.
- The organization pays $139,545,675 in salary, compensation, and benefits to its employees.
- The organization pays $3,186,635 in fundraising expenses.
Additional Non-Profits in the area
By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.